$XOMA Headlines S&P 500 stages ‘the expected
Post# of 72711
Posted On: 12/10/2014 10:17:26 AM
$XOMA Headlines
S&P 500 stages ‘the expected’ break to all-time highs 12:04 p.m. Feb. 28, 2014 - Michael Ashbaugh
Restoration Hardware shares fall on co-CEO resigning 6:07 p.m. Dec. 12, 2013 - Wallace Witkowski
3 new bets by a biotech hedge fund 3:56 a.m. July 10, 2012 - The Trading Deck
XOMA wins US rights to market blood pressure drugs 5:56 p.m. Jan. 17, 2012 - MarketWatch.com
Today's Perilous Reversal Stock: XOMA (XOMA) 9:47 a.m. Dec. 9, 2014 - TheStreet.com
XOMA Announces Pricing Of $40.0M Registered Offering Of Common Stock And Warrants 8:02 a.m. Dec. 9, 2014 - benzinga.com
InsiderInsights.com Daily Round Up 12/4/14: GPRO, XOMA, PSEC, KMT 6:22 p.m. Dec. 5, 2014 - Seeking Alpha
Strong On High Relative Volume: XOMA (XOMA) 10:05 a.m. Dec. 5, 2014 - TheStreet.com
XOMA (XOMA) Stock: Weak On High Volume Today 10:03 a.m. Dec. 3, 2014 - TheStreet.com
XOMA Corp Worth Watching: Stock Moves 10.3% Higher - Tale of the Tape 9:46 a.m. Nov. 21, 2014 - Zacks.com
Trade-Ideas: XOMA (XOMA) Is Today's Strong On High Relative Volume Stock 10:02 a.m. Nov. 20, 2014 - TheStreet.com
XOMA's (XOMA) Presents at Credit Suisse 2014 Healthcare Conference Call (Transcript) 11:49 p.m. Nov. 12, 2014 - Seeking Alpha
XOMA Corp Volatile Amid Differing Analyst Reports 10:45 a.m. Nov. 10, 2014 - benzinga.com
XOMA (XOMA) Stock: Weak On High Volume Today 10:02 a.m. Nov. 7, 2014 - TheStreet.com
XOMA's (XOMA) CEO John Varian on Q3 2014 Results - Earnings Call Transcript 10:29 p.m. Nov. 6, 2014 - Seeking Alpha
XOMA (XOMA) Q3 2014 Results - Earnings Call Webcast 4:25 p.m. Nov. 6, 2014 - Seeking Alpha
3 Biotech Stocks for Earnings Beats this Season - Earnings ESP 1:38 p.m. Nov. 5, 2014 - Zacks.com
3 Biotech Stocks for Earnings Beats this Season - Earnings ESP 1:38 p.m. Nov. 5, 2014 - Zacks.com
Should You Buy XOMA Corporation (XOMA) Ahead of Earnings? - Tale of the Tape 8:45 a.m. Nov. 5, 2014 - Zacks.com
Xoma PG trial open for enrollment 1:05 p.m. Nov. 4, 2014 - Seeking Alpha
Looking For My Next Triple In Biotech 1:26 p.m. Oct. 31, 2014 - Seeking Alpha
XOMA Starts Phase I Study on XOMA 358 for Hyperinsulinism - Analyst Blog 5:10 p.m. Oct. 10, 2014 - Zacks.com
XOMA Launches XOMA 358 Clinical Development 8:22 a.m. Oct. 9, 2014 - benzinga.com
XOMA Licensing Manufacturing Tech To Texas A&M, No Terms Disclosed 12:05 p.m. Oct. 6, 2014 - benzinga.com
XOMA Announces Pricing of $40.0 Million Registered Offering of Common Stock and Warrants 9:01 a.m. Dec. 9, 2014 - GlobeNewswire
XOMA to Present at the Piper Jaffray Healthcare Conference 3:09 p.m. Nov. 24, 2014 - GlobeNewswire
Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 9:00 a.m. Nov. 18, 2014 - PR Newswire - PRF
XOMA to Present at Upcoming Investor Conferences 2:18 p.m. Nov. 10, 2014 - GlobeNewswire
XOMA Highlights Recent Achievements and Reports Financial Results for the Third Quarter of 2014 4:02 p.m. Nov. 6, 2014 - GlobeNewswire
XOMA Initiates Pivotal Phase 3 Gevokizumab Study in Patients With Pyoderma Gangrenosum 9:02 a.m. Nov. 4, 2014 - GlobeNewswire
XOMA to Announce Third Quarter 2014 Financial Results and Host Webcast on November 6 1:50 p.m. Oct. 27, 2014 - GlobeNewswire
Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 8:30 a.m. Oct. 17, 2014 - PR Newswire - PRF
XOMA Launches XOMA 358 Clinical Development 8:02 a.m. Oct. 9, 2014 - GlobeNewswire
The Texas A&M University System and XOMA License Innovative Manufacturing Technology 12:01 p.m. Oct. 6, 2014 - GlobeNewswire
XOMA Initiates U.S. Clinical Trial of Gevokizumab in Patients With Behcet's Disease Uveitis - EYEGUARD(TM)-US 3:05 p.m. Sept. 30, 2014 - GlobeNewswire
Biotech Stocks in Motion - XOMA, Nanosphere, Isis Pharma, Halozyme Therapeutics, and Synta Pharma 7:45 a.m. Sept. 17, 2014 - PR Newswire - PRF
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 7:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Global Uveitis Market 2014-2018.pdf 1:38 p.m. Aug. 12, 2014 - PR Newswire - PRF
XOMA Highlights Recent Achievements and Reports Financial Results for Second Quarter 2014 3:02 p.m. Aug. 7, 2014 - GlobeNewswire
XOMA to Present at Two Upcoming Investor Conferences 1:56 p.m. Aug. 6, 2014 - GlobeNewswire
XOMA to Announce Second Quarter 2014 Financial Results and Host Webcast on August 7 12:16 p.m. July 30, 2014 - GlobeNewswire
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 6:20 a.m. July 10, 2014 - PR Newswire - PRF
XOMA Call Today at 4:30pm ET/1:30pm PT to Confirm Communication Plan for EYEGUARD(TM)-B Clinical Program 3:02 p.m. June 30, 2014 - GlobeNewswire
Health Care Sector Stocks Highlight -- Research on XOMA, Novartis, Catamaran, and Castlight Health 4:20 a.m. June 2, 2014 - PR Newswire - PRF
S&P 500 stages ‘the expected’ break to all-time highs 12:04 p.m. Feb. 28, 2014 - Michael Ashbaugh
Restoration Hardware shares fall on co-CEO resigning 6:07 p.m. Dec. 12, 2013 - Wallace Witkowski
3 new bets by a biotech hedge fund 3:56 a.m. July 10, 2012 - The Trading Deck
XOMA wins US rights to market blood pressure drugs 5:56 p.m. Jan. 17, 2012 - MarketWatch.com
Today's Perilous Reversal Stock: XOMA (XOMA) 9:47 a.m. Dec. 9, 2014 - TheStreet.com
XOMA Announces Pricing Of $40.0M Registered Offering Of Common Stock And Warrants 8:02 a.m. Dec. 9, 2014 - benzinga.com
InsiderInsights.com Daily Round Up 12/4/14: GPRO, XOMA, PSEC, KMT 6:22 p.m. Dec. 5, 2014 - Seeking Alpha
Strong On High Relative Volume: XOMA (XOMA) 10:05 a.m. Dec. 5, 2014 - TheStreet.com
XOMA (XOMA) Stock: Weak On High Volume Today 10:03 a.m. Dec. 3, 2014 - TheStreet.com
XOMA Corp Worth Watching: Stock Moves 10.3% Higher - Tale of the Tape 9:46 a.m. Nov. 21, 2014 - Zacks.com
Trade-Ideas: XOMA (XOMA) Is Today's Strong On High Relative Volume Stock 10:02 a.m. Nov. 20, 2014 - TheStreet.com
XOMA's (XOMA) Presents at Credit Suisse 2014 Healthcare Conference Call (Transcript) 11:49 p.m. Nov. 12, 2014 - Seeking Alpha
XOMA Corp Volatile Amid Differing Analyst Reports 10:45 a.m. Nov. 10, 2014 - benzinga.com
XOMA (XOMA) Stock: Weak On High Volume Today 10:02 a.m. Nov. 7, 2014 - TheStreet.com
XOMA's (XOMA) CEO John Varian on Q3 2014 Results - Earnings Call Transcript 10:29 p.m. Nov. 6, 2014 - Seeking Alpha
XOMA (XOMA) Q3 2014 Results - Earnings Call Webcast 4:25 p.m. Nov. 6, 2014 - Seeking Alpha
3 Biotech Stocks for Earnings Beats this Season - Earnings ESP 1:38 p.m. Nov. 5, 2014 - Zacks.com
3 Biotech Stocks for Earnings Beats this Season - Earnings ESP 1:38 p.m. Nov. 5, 2014 - Zacks.com
Should You Buy XOMA Corporation (XOMA) Ahead of Earnings? - Tale of the Tape 8:45 a.m. Nov. 5, 2014 - Zacks.com
Xoma PG trial open for enrollment 1:05 p.m. Nov. 4, 2014 - Seeking Alpha
Looking For My Next Triple In Biotech 1:26 p.m. Oct. 31, 2014 - Seeking Alpha
XOMA Starts Phase I Study on XOMA 358 for Hyperinsulinism - Analyst Blog 5:10 p.m. Oct. 10, 2014 - Zacks.com
XOMA Launches XOMA 358 Clinical Development 8:22 a.m. Oct. 9, 2014 - benzinga.com
XOMA Licensing Manufacturing Tech To Texas A&M, No Terms Disclosed 12:05 p.m. Oct. 6, 2014 - benzinga.com
XOMA Announces Pricing of $40.0 Million Registered Offering of Common Stock and Warrants 9:01 a.m. Dec. 9, 2014 - GlobeNewswire
XOMA to Present at the Piper Jaffray Healthcare Conference 3:09 p.m. Nov. 24, 2014 - GlobeNewswire
Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 9:00 a.m. Nov. 18, 2014 - PR Newswire - PRF
XOMA to Present at Upcoming Investor Conferences 2:18 p.m. Nov. 10, 2014 - GlobeNewswire
XOMA Highlights Recent Achievements and Reports Financial Results for the Third Quarter of 2014 4:02 p.m. Nov. 6, 2014 - GlobeNewswire
XOMA Initiates Pivotal Phase 3 Gevokizumab Study in Patients With Pyoderma Gangrenosum 9:02 a.m. Nov. 4, 2014 - GlobeNewswire
XOMA to Announce Third Quarter 2014 Financial Results and Host Webcast on November 6 1:50 p.m. Oct. 27, 2014 - GlobeNewswire
Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 8:30 a.m. Oct. 17, 2014 - PR Newswire - PRF
XOMA Launches XOMA 358 Clinical Development 8:02 a.m. Oct. 9, 2014 - GlobeNewswire
The Texas A&M University System and XOMA License Innovative Manufacturing Technology 12:01 p.m. Oct. 6, 2014 - GlobeNewswire
XOMA Initiates U.S. Clinical Trial of Gevokizumab in Patients With Behcet's Disease Uveitis - EYEGUARD(TM)-US 3:05 p.m. Sept. 30, 2014 - GlobeNewswire
Biotech Stocks in Motion - XOMA, Nanosphere, Isis Pharma, Halozyme Therapeutics, and Synta Pharma 7:45 a.m. Sept. 17, 2014 - PR Newswire - PRF
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 7:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Global Uveitis Market 2014-2018.pdf 1:38 p.m. Aug. 12, 2014 - PR Newswire - PRF
XOMA Highlights Recent Achievements and Reports Financial Results for Second Quarter 2014 3:02 p.m. Aug. 7, 2014 - GlobeNewswire
XOMA to Present at Two Upcoming Investor Conferences 1:56 p.m. Aug. 6, 2014 - GlobeNewswire
XOMA to Announce Second Quarter 2014 Financial Results and Host Webcast on August 7 12:16 p.m. July 30, 2014 - GlobeNewswire
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 6:20 a.m. July 10, 2014 - PR Newswire - PRF
XOMA Call Today at 4:30pm ET/1:30pm PT to Confirm Communication Plan for EYEGUARD(TM)-B Clinical Program 3:02 p.m. June 30, 2014 - GlobeNewswire
Health Care Sector Stocks Highlight -- Research on XOMA, Novartis, Catamaran, and Castlight Health 4:20 a.m. June 2, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼